278650 — HLB BioStep Co Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareHighly SpeculativeSmall CapSucker Stock

Market Cap
KR₩139bn
Enterprise Value
KR₩134bn
Revenue
KR₩58bn

Annual balance sheet for HLB BioStep Co, fiscal year end - December 31st, KRW millions except per share, conversion factor applied.

	2020 December 31st	R2021 December 31st	R2022 December 31st	2023 December 31st	2024 December 31st
Period Length:	—	—	—	—	—
Source:	Annual Audited Accounts	Annual Audited Accounts	Interim Report	Annual Audited Accounts	Annual Audited Accounts
Standards:	IFRS	IFRS	IFRS	IFRS	IFRS
Status:	Final	Final	Final	Final	Final
Cash
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments	14,910	10,393	97,045	70,358	46,842
Net Total Accounts Receivable
Net Total Receivables	8,829	10,153	10,148	6,629	12,610
Total Inventory
Prepaid Expenses
Total Other Current Assets
Total Current Assets	28,579	31,178	112,424	79,413	62,478
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	26,226	39,867	39,626	40,678	52,094
Net Goodwill
Net Intangible Assets
Long Term Investments
Long Term Notes Receivable
Other Long Term Assets
Total Assets	74,215	94,626	172,187	171,714	168,329
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	15,379	16,582	12,775	64,682	46,285
Long Term Debt
Capital Lease Obligations
Total Long Term Debt
Total Debt
Minority Interest
Total Other Liabilities
Total Funded Status
Total Liabilities	20,572	30,038	101,909	70,124	56,455
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Treasury Stock
ESOP Debt Guarantee
Unrealized Gain / Loss
Other Equity
Total Equity	53,643	64,587	70,278	101,590	111,874
Total Liabilities & Shareholders' Equity	74,215	94,626	172,187	171,714	168,329
Total Common Shares Outstanding